Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,098,000 | 9,746,000 | 12,182,000 | 8,546,000 | 9,755,000 |
| Marketable Securities | 1,474,000 | 84,000 | 67,000 | 54,000 | 22,000 |
| Receivables | 10,733,000 | 9,977,000 | 9,281,000 | 9,914,000 | 9,588,000 |
| Inventories | 3,483,000 | 3,128,000 | 3,094,000 | 3,386,000 | 3,272,000 |
| TOTAL | $26,509,000 | $27,928,000 | $28,957,000 | $25,999,000 | $26,569,000 |
| Non-Current Assets | |||||
| PPE Net | 5,075,000 | 5,110,000 | 5,130,000 | 5,161,000 | 5,193,000 |
| Investments And Advances | 260,000 | 277,000 | 272,000 | 266,000 | 305,000 |
| Intangibles | 106,284,000 | 108,330,000 | 109,752,000 | 111,738,000 | 113,642,000 |
| Other Non-Current Assets | 5,083,000 | 4,884,000 | 4,747,000 | 4,808,000 | 4,792,000 |
| TOTAL | $116,702,000 | $118,601,000 | $119,901,000 | $121,973,000 | $123,932,000 |
| Total Assets | $143,211,000 | $146,529,000 | $148,858,000 | $147,972,000 | $150,501,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 9,952,000 | 12,495,000 | 6,672,000 | 7,901,000 | 11,347,000 |
| Accounts payable and accrued liabilities | 22,569,000 | 22,699,000 | 21,861,000 | 20,783,000 | 20,604,000 |
| TOTAL | $32,521,000 | $35,194,000 | $28,533,000 | $28,684,000 | $31,951,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 63,522,000 | 64,189,000 | 74,049,000 | 74,237,000 | 74,183,000 |
| Other Non-Current Liabilities | 28,020,000 | 28,700,000 | 29,096,000 | 28,793,000 | 26,864,000 |
| TOTAL | $94,376,000 | $95,899,000 | $106,748,000 | $106,694,000 | $104,817,000 |
| Total Liabilities | $126,897,000 | $131,093,000 | $135,281,000 | $135,378,000 | $136,768,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,767,110 | 1,768,754 | 1,767,880 | 1,767,176 | 1,766,222 |
| Common Shares | 18,000 | 18,000 | 18,000 | 18,000 | 18,000 |
| Retained earnings | 5,103,000 | 3,127,000 | 1,600,000 | 740,000 | 2,292,000 |
| Other shareholders' equity | -2,953,000 | -2,871,000 | -3,129,000 | -3,078,000 | -3,272,000 |
| TOTAL | $16,314,000 | $15,436,000 | $13,577,000 | $12,594,000 | $13,733,000 |
| Total Liabilities And Equity | $143,211,000 | $146,529,000 | $148,858,000 | $147,972,000 | $150,501,000 |